Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

109 results about "Dicaffeoylquinic acid" patented technology

Stevia rebaudian valid target as well as its activity and application

The invention discloses an effective part of stevia and the activity and the application thereof. The effective part mainly comprises stevioside category and flavone category which are obtained by extracting and separating from dried stevia leaves, wherein the sum of the percentage content of the stevioside components in the stevioside part is 5 to 100 percent (w/w), and the stevioside components mainly contains the stevioside, stevibioside, rebaudioside A, B, C, D, E, and F, dulcoside A and the derivative thereof, etc.; the sum of the percentage content of the flavone components in the flavone part is 5 to 100 percent (w/w), and the flavone components mainly contains luteolin, quercetin, luteolin-7-O-Beta-D-glucoside, apigenin-7-O-Beta-D-glucoside, quercitrin, quercetin-3-O-Beta-D-arabinoside, quercetin-3-O-(4-O-anti form-caffeoyl acyl-Alpha-L-rhamnose-(1 to 6)-Beta-D-galactoside) and the derivative thereof, etc., and 4, 5-dicaffeoylquinic acid and the derivative thereof, etc. The effective part has significant sugar-reducing and fat-reducing effects, can be used singly or combined with any other Chinese medicines and Western medicines or foods in any proportion, is used for preparing medicines or functional foods, and is used for treating hyperglycemia and hyperlipoidemia.
Owner:石任兵

Separation and purification methods of highly purified antiviral active components in artichoke

The invention discloses a method for efficiently separating and preparing highly purified antiviral active components (single caffeoylquinic acid compound and dicaffeoylquinic acid compound) in artichoke, mainly comprising the following steps: utilizing alcohol aqueous solution to extract fresh or dry artichoke, concentrating, carrying out column chromatographic separation, preparing crude extract rich in the antiviral active components, carrying out separation and purification on the crude extract by combing high speed counter-current chromatography with high preparative performance liquid chromatography, and finally adopting a recrystallization method for refining to obtain highly purified 1-O-caffeoylquinic acid, 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid, 1,3-di-O-caffeoylquinic acid, 1,5-di-O-caffeoylquinic acid, 3,5-di-O-caffeoylquinic acid, 3,4-di-O-caffeoyl quinine acid and 4,5-di-O-caffeoylquinic acid. The method is suitable for preparing highly purified monomer by utilizing various natural products or the extractives of the natural products containing one or more components containing the above caffeoylquinic acid compounds as raw materials, wherein the natural products or the extractives are obtained from various ways; and the method has simple steps, simple operation, high efficiency, low cost and large separating preparation quantity, is easy to repeat; and the purification of the caffeoylquinic acid compounds prepared by the method can be up to 98%.
Owner:CENT SOUTH UNIV

Phlegm-heat clearing injection fingerprint spectrum establishment method and fingerprint spectrum thereof

The invention relates to the technical field of medicine detection, and in particular relates to a phlegm-heat clearing injection fingerprint spectrum establishment method and a fingerprint spectrum thereof; the phlegm-heat clearing injection is prepared from scutellaria baicalensis, bear gall powder, cornu gorais, honeysuckle and fructus forsythiae, and a phlegm-heat clearing injection fingerprint spectrum is established by detecting the phlegm-heat clearing injection components by adopting an ultra-high performance liquid chromatography method; the method specifically comprises the followingsteps of S1, preparing a reference substance solution: taking a proper amount of caffeic acid, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, 3, 4-dicaffeoylquinic acid and 3, 5-dicaffeoylquinic acid, 4, 5-dicaffeoylquinic acid, forsythiaside D, baicalin, scutellarin, chrysin-7-O-glucuronide, oroxylin-7-O-glucuronide and a wogonin reference substance, and adding methanol to prepare a solution which is 20-50 [mu]g in 1ml. according to the phlegm-heat clearing injection fingerprint spectrum establishment method provided by the invention, the method is simple and convenient to operate, stable in result, high in reproducibility and high in precision.
Owner:SHANGHAI KAIBAO PHARMA

Production method for chlorogenic acid and dicaffeoylquinic acid through induction and culture of hairy roots of stevia rebaudiana

ActiveCN103695462AHigh and stable chlorogenic acidHigh and stable dicaffeoylquinic acid contentOrganic chemistryGenetic engineeringDicaffeoylquinic acidRhizobium rhizogenes
The invention belongs to the field of genetic engineering, specifically to a production method for chlorogenic acid and dicaffeoylquinic acid by establishing a hairy root culture system through genetic transformation of stevia rebaudiana with agrobacterium rhizogenes. The method comprises the following steps: preparation of an explant of stevia rebaudiana, activation and culture of agrobacterium rhizogenes, suspension culture and production of chlorogenic acid and dicaffeoylquinic acid. PCR detection results show that hairy roots of stevia rebaudiana are generated through transformation; HPLC detection results show that the hairy roots of stevia rebaudiana can produce chlorogenic acid and dicaffeoylquinic acid. Since the hairy roots used in the invention have the characteristic of rapid growth on a hormone-free medium, the method provided by the invention has the advantages of simple operation, low cost, no restriction by natural conditions like climate and land, etc. A stable and sustainable novel drug source and food function factors are provided for production of chlorogenic acid and dicaffeoylquinic acid through culture of the hairy roots, and a reliable source and a reliable substance base are provided for large scale production of chlorogenic acid and dicaffeoylquinic acid by using a bioreactor in the future.
Owner:JIANGXI AGRICULTURAL UNIVERSITY

Thin-layer chromatography identification method forwild chrysanthemum medicinal material and formula granule and application

The invention relates to a thin-layer chromatography identification method for a wild chrysanthemum medicinal material and formula granules. The thin-layer chromatograms of the wild chrysanthemum medicinal material and formula granules are compared with the chromatograms of a wild chrysanthemum reference medicinal material as well as chlorogenic acid, linarin, 4,5-dicaffeoylquinic acid, 3, 5-O-dicaffeoylquinic acid, galuteolin and luteolin reference substance; so that effective components in the wild chrysanthemum medicinal material and formula granules can be rapidly and effectively identified. three isomers namely, chlorogenic acid, 4,5-dicaffeoylquinic acid and 3, 5-O-dicaffeoylquinic acid and two natural flavonoid compounds, namely,the galuteolin and luteolin in the wild chrysanthemumflower medicinal material and formula granules are identified by thin-layer chromatography for the first time; and the wild chrysanthemum flower medicinal material and the formula granules can be enriched, separated and purified at corresponding Rf positions of a silica gel plate by using the method. The chlorogenic acid, the isomeride component of chlorogenic acid, and the flavonoid compounds canbe prepared, so that high commercial value can be realized. The method is environmentally friendly and convenient to operate, good in repeatability and specificity and good in application prospect.
Owner:劲牌持正堂药业有限公司

Method for bioconversion of chlorogenic acids in plants by adopting aspergillus aculeatus

The invention relates to a method for directionally converting and purifying chlorogenic acids by using aspergillus aculeatus CCTCC No.M2011264 and an enzyme liquid of the aspergillus aculeatus. The method comprises the following steps: the aspergillus aculeatus is inoculated to a liquid or solid enzyme generation culture medium, the fungus or enzyme obtained from fermentation is used for converting plant extracting solution or powder containing the chlorogenic acids. According to the invention, 1, 5-dicaffeoylquinic acid in the system of the method is reserved in the solution rather than being converted, and the solution can be purified as partial compositions are consumed during the conversion process (for example, 99% above of 4, 5-dicaffeoylquinic acid with property extremely similar to the that of the 1, 5-dicaffeoylquinic acid is consumed), so that the follow-up separation and purification steps are eliminated, and the method can be taken as a novel method for purifying the 1, 5-dicaffeoylquinic acid; besides, through controlling the conversion condition, the limitation that only caffeic acid, ferulic acid and quinic acid can be obtained by adopting the conventional conversion method is overcome.
Owner:巴州正达绿源生物科技有限公司

Method for preparing a plurality of caffeoylquinic acid monomers from honeysuckle

The invention relates to a method for preparing a plurality of caffeoylquinic acid monomers from honeysuckle, and belongs to preparation methods for chemical substances or drugs. In the prior art, caffeoylquinic acid substances prepared by the existing method do not have high purity; the existing chlorogenic acid extraction and preparation technology has a disadvantage of high organic solvent consumption so as to cause environmental pollution, or adopts a complex separation technology, such that production enlarging is difficult; and extraction efficiency is not high, raw material utilization rate is low, and other problems exist. With the present invention, the problems in the prior art are solved, and high purity 3-caffeoylquinic acid, high purity 4-caffeoylquinic acid, high purity 2-caffeoylquinic acid, high purity 4,5-dicaffeoylquinic acid, high purity 3,4-dicaffeoylquinic acid and other monomer components are obtained. In addition, the project technology comprises a raw material pretreatment step, an extraction step, a macromolecule precipitation step, a macroporous resin separation step, a reversed phase column separation step, a crystallization step and the like, such that production cost is saved, production efficiency is improved, the process is simple and easily enlarged into industrialization production, and the raw material utilization rate can be greatly improved.
Owner:HUBEI CHUTIANSHU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products